FDA investigating tramadol use in children

Posted in Latest News on November 23, 2015.

The FDA posted the following alert on use of tramadol for children ages 17 and younger:

FDA is investigating the use of the pain medicine tramadol in children aged 17 years and younger, because of the rare but serious risk of slowed or difficult breathing. This risk may be increased in children treated with tramadol for pain after surgery to remove their tonsils and/or adenoids. FDA is evaluating all available information and will communicate final conclusions and recommendations to the public when the review is complete.

Tramadol is not FDA-approved for use in children; however, data show it is being used “off-label” in the pediatric population. Health care professionals should be aware of this and consider prescribing alternative FDA-approved pain medicines for children.



More Latest News

First Quarterly Performance Report Released for the 2017-2018 Fiscal Year
April 15, 2018

The Quarterly Performance Report for the first quarter of the 2017-2018 fiscal year is now available online. Continue reading


House Bill 323 – Meningococcal and Shingles Vaccines
March 30, 2018

Click here for more information on authorization for pharmacists to administer meningococcal and shingles vaccines under certain circumstances. Continue reading